Similar articles

• Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.

  Yacobi A, Gibson TP, McEntegart CM, Hulse JD. Yacobi A, et al. Res Commun Chem Pathol Pharmacol. 1982 May;36(2):199-204. Res Commun Chem Pathol Pharmacol. 1982. PMID: 6179136
• [Hyperamylasemia following infusion of hydroxyethyl starch with different molecular weight distributions].

  Gofferje H, Kozlik V. Gofferje H, et al. Infusionsther Klin Ernahr. 1977 Jun;4(3):141-4. Infusionsther Klin Ernahr. 1977. PMID: 70402 German.
• [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].

  Mishler JM 4th. Mishler JM 4th. Infusionsther Klin Ernahr. 1980 Apr;7(2):96-102. Infusionsther Klin Ernahr. 1980. PMID: 6159323 German.
• [Structural analysis of starch. (1) Bacillus subtilis alpha-amylase].

  Okada G, Ohnishi M, Sakano Y, Taniguchi H. Okada G, et al. Tanpakushitsu Kakusan Koso. 1985 Mar;30(3):220-6. Tanpakushitsu Kakusan Koso. 1985. PMID: 3923560 Review. Japanese. No abstract available.
• Hetastarch: an overview of the colloid and its metabolism.

  Hulse JD, Yacobi A. Hulse JD, et al. Drug Intell Clin Pharm. 1983 May;17(5):334-41. doi: 10.1177/106002808301700503. Drug Intell Clin Pharm. 1983. PMID: 6190620 Review.